New study explains why so many Q10 preparations are ineffective

According to a new Italian review article, the problem with many Q10 products is that the active ingredient never reaches the blood and tissue. Read more about this and what it takes to manufacture a Q10 preparation that is absorbed properly by the digestive system.

Thousands of studies have been conducted with coenzyme Q10, a vitamin-like compound that we humans have inside the energy-producing mitochondria of our cells. Surprisingly, only some of the studies have shown convincing outcome. Is there a reason for that? Well, according to a large review¹ that was published recently in the science journal Antioxidants, part of the explanation may lie in the fact that only few Q10 preparations are absorbed properly and can actually vouch for their quality.

¹⁾ Antioxidants 2020, 9, 341

Unable to pass through the intestinal membrane

In brief, the challenge with coenzyme Q10 is that the molecules aggregate and form large insoluble crystals that are unable to pass through the intestinal membrane into the bloodstream. Instead, the crystal formations continue through the digestive system and are eventually excreted.

Documented in groundbreaking study

The formula that Pharma Nord developed has been shown to work. In fact, it was used in a study that the Italian researchers refer to as “one of the most important studies of nutraceuticals”. Q-SYMBIO, as this groundbreaking trial is named, was published in Journal of the American College of Cardiology (JAAC) in 2014. The product that was used is called Myoquinone and it is one of the Q10 brands that is included in the above-mentioned Italian review article.